GlassScriptPhysician profile
Randall C Gilbert
NPI 1790737526
$5,594.89
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,008 · 2020: $1,735 · 2021: $2,758 · 2022: $94.14.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,524.20 | 2019-2022 | |
| Glaxosmithkline, LLC. | $646.78 | 2020-2021 | |
| Horizon Therapeutics Plc | $564.39 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $549.24 | 2020-2021 | |
| Amgen INC. | $486.65 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $272.66 | 2021-2022 | |
| Lilly USA, LLC | $261.59 | 2019-2021 | |
| Janssen Biotech, INC. | $201.77 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $194.57 | 2019-2022 | |
| Pfizer INC. | $192.80 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $175.34 | 2019 | |
| Ucb, INC. | $142.74 | 2021 | |
| Radius Health, INC. | $108.85 | 2021 | |
| Genzyme Corporation | $62.36 | 2019-2020 | |
| Vertiflex, INC. | $56.70 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $56.05 | 2019-2020 | |
| Aurinia Pharma U.S., INC. | $43.14 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.05 | 2021 | |
| Celgene Corporation | $17.64 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.